MACKENZIE FINANCIAL CORP – Regeneron Pharmaceuticals, Inc. Transaction History
MACKENZIE FINANCIAL CORP portfolio value:
$56.30M
portfolio value
MACKENZIE FINANCIAL CORP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.42% | -7.51K shares | 3.54M | $688.87 | 81.73K |
| Q2 2022 | share | Decrease | -4.96% | -4.66K shares | -12.83M | $591.13 | 89.24K |
| Q1 2022 | share | Increase | +6.46% | 5.70K shares | 9.88M | $698.42 | 93.91K |
| Q4 2021 | share | Decrease | -0.41% | -362 shares | 2.10M | $642.51 | 88.20K |
| Q3 2021 | share | Increase | +0.13% | 119 shares | 4.19M | $605.18 | 88.57K |
| Q2 2021 | share | Increase | +26.05% | 18.28K shares | 16.20M | $558.54 | 88.45K |
| Q1 2021 | share | Increase | +90.30% | 33.29K shares | 15.38M | $473.14 | 70.16K |
| Q4 2020 | share | Increase | +17.40% | 5.46K shares | 232K | $483.11 | 36.87K |
| Q3 2020 | share | Increase | +34.90% | 8.12K shares | 3.06M | $559.78 | 31.40K |
| Q2 2020 | share | Increase | +24.10% | 4.52K shares | 5.35M | $623.65 | 23.28K |
| Q1 2020 | share | Increase | +3.26% | 593 shares | 2.33M | $488.29 | 18.76K |
| Q4 2019 | share | Increase | +427.22% | 14.72K shares | 5.86M | $375.48 | 18.16K |
| Q3 2019 | share | Increase | +258.58% | 2.48K shares | 655K | $277.4 | 3.44K |
| Q2 2019 | share | Decrease | -85.89% | -5.85K shares | -2.49M | $313 | 961 |
| Q1 2019 | share | Increase | +352.93% | 5.30K shares | 2.23M | $410.62 | 6.81K |
| Q4 2018 | share | Decrease | -0.27% | -4 shares | -47K | $373.5 | 1.50K |
| Q3 2018 | share | Increase | +17.54% | 225 shares | 166K | $404.04 | 1.50K |
| Q2 2018 | share | Increase | +26.78% | 271 shares | 95K | $344.99 | 1.28K |
| Q1 2018 | share | Increase | +86.37% | 469 shares | 144K | $344.36 | 1.01K |
| Q4 2017 | share | Increase | 0.00% | 543 shares | 204K | $375.96 | 543 |